Back to top
more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$6.55 USD

6.55
991,294

+0.10 (1.55%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $6.54 -0.01 (-0.15%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter 2023 results reflect the persistence of macroeconomic challenges and hurdles related to business transformation, offset by growth in some regions.

Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 27.59% and 1.94%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter 2023 earnings will likely reflect the adverse impact of macroeconomic challenges like a slowdown in consumer spending. Unfavorable currency translations pose concerns.

Philip Morris (PM) Lags Q4 Earnings Estimates

by Zacks Equity Research

Philip Morris (PM) delivered earnings and revenue surprises of -5.56% and 0.98%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for PEY

Product Launches Aid Nu Skin (NUS), Macroeconomic Hurdles Ail

by Zacks Equity Research

Nu Skin (NUS) is benefiting from the Nu Vision 2025 strategy driven by a dynamic affiliate opportunity platform. However, escalating macroeconomic pressures are hampering key markets.

Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why

by Zacks Equity Research

Nu Skin (NUS) is battling escalating macroeconomic pressures, which are hampering key markets of the core business. Unfavorable currency translations remain a major concern.

Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?

by Zacks Equity Research

Inter Parfums (IPAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance

by Zacks Equity Research

Nu Skin (NUS) faces challenging y/y comparisons and macroeconomic hurdles in Q3, leading to a downward revision in its revenue and EPS projections for 2023.

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

by Zacks Equity Research

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?

by Zacks Equity Research

e.l.f. Beauty's (ELF) strong business fundamentals, strategic acquisitions, focus on innovation and international expansion position it favorably ahead of its Q2 earnings release.

Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings

by Zacks Equity Research

Nu Skin's (NUS) third-quarter 2023 earnings will likely reflect macroeconomic challenges, including a slowdown in consumer spending. Nevertheless, strength in the Nu Vision 2025 strategy bodes well.

Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

by Zacks Equity Research

Nu Skin (NUS) is on track with its Nu Vision 2025 strategy. However, the company is operating amid macroeconomic hurdles.

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

by Zacks Equity Research

Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movements.

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

by Zacks Equity Research

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.

Nu Skin (NUS) Down 11.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

by Zacks Equity Research

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.

Nu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings Beat

by Zacks Equity Research

Nu Skin (NUS) reports sequential improvements in Q2 results, driven by the Mainland China and Rhyz segments. However, macro-economic factors pose challenges in the key markets.

Nu Skin Enterprises (NUS) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 1.89% and 2.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.

COTY Inks Agreement to Offload 3.6% of Its Stake in Wella

by Zacks Equity Research

COTY inks a letter of intent to divest part of its stake in Wella to IGF Wealth Management. This is likely to help the company meet its leverage goal toward 3X as it exits CY23.

Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.